News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
GeneLink, Inc. Reports First Quarter Results Revenues Approximately $2.0M
May 21, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ORLANDO, Fla.--(BUSINESS WIRE)--GeneLink, Inc. (OTCBB:GNLK.OB, “the Company,” or “GeneLink”), a leading consumer genomics biotech company, today reported financial results for the fiscal 2009 three-month period ended March 31, 2009.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Manufacturing
Viatris recalls extended-release Xanax over dissolution test failure
April 20, 2026
·
2 min read
·
Nick Paul Taylor
Mergers & acquisitions
Lilly adds gene delivery technology to CAR T in up to $7B Kelonia deal
April 20, 2026
·
2 min read
·
Annalee Armstrong
Cell therapy
Agenus cancer cocktail records 0% response rate, missing midstage goal
April 20, 2026
·
2 min read
·
Gabrielle Masson
IPO tracker
Odyssey tests IPO waters anew after quitting quest last year
April 20, 2026
·
10 min read
·
Tristan Manalac